「et」の検索結果
138件：21～25件目を表示
-
お知らせ | 千寿製薬株式会社
t of Dry Eye Disease through TRPV1 Inhibition（PDF） December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Diseas...
http://www.senju.co.jp/english/news/ -
Publications | Research & Development | SENJU Pharmaceutica
藍2) 坂本祐一郎2) 末信敏秀2) 井上幸次3) 1) 愛媛大学医学部眼科学教室 2)千寿製薬株式会社 3)日野病院 あたらしい眼科42(12)：1566～1576 Efficacy and Safety of SJP-0132 in Patients with Dry Eye Disease: A Phase 2b Randomized, Double-Masked, Dose-Finding...
http://www.senju.co.jp/english/rd/thesis/ -
Research and Development System | Research & Development | SENJU Pharmaceutica
n, “First in Class” products are defined as “groundbreaking products with excellent efficacy and safety achieved through a new mechanism of action.” In other words, by creating “First in Class” produc...
http://www.senju.co.jp/english/rd/about/ -
Overseas Activities | SENJU Pharmaceutical
a, we established a local subsidiary, Jiangsu Senju Pharmaceutical Co., Ltd., to strengthen our marketing system and steadily lay the groundwork for globalization. Overseas bases BEIJING OFFICEBeijing...
http://www.senju.co.jp/english/global/ -
CEO Message | About Senju | SENJU Pharmaceutical
e company concept that helps us see the perspective of others.Changes in the environment of our society and medical care occur with increasing speed. In these difficult times, we stand steadfastly by ...
http://www.senju.co.jp/english/about/message.html